-
BARDA Reselects ICON as Preferred Partner
contractpharma
October 30, 2020
ICON plc, a global CRO, has been re-selected by the Biomedical Advanced Research and Development Authority (BARDA) to continue being part of its exclusive Medical Countermeasures Clinical Studies Network (CSN).
-
Beckman Coulter Receives Funding to Validate Monocyte Distribution Width in MIS-C Detection
americanpharmaceuticalreview
October 22, 2020
Beckman Coulter has been awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services ...
-
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
worldpharmanews
October 21, 2020
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
-
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
prnewswire
October 16, 2020
Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the Assistant Secretary for Preparedness and Response at ...
-
HHS Funds Development of Needle-free Vax Technology
contractpharma
October 10, 2020
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.
-
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
contractpharma
October 10, 2020
Will support new medical countermeasure research in the fight against emerging infectious disease.
-
Ortho Awarded Contract to Accelerate Antigen Test Development
americanpharmaceuticalreview
September 27, 2020
Ortho Clinical Diagnostics announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and ...
-
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones
prnasia
September 22, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and...
-
Moderna Announces COVID-19 Vaccine Supply Agreement with U.S. Government
americanpharmaceuticalreview
August 19, 2020
Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people.
-
Moderna to get additional $472m from BARDA for Covid-19 vaccine
pharmaceutical-technology
July 28, 2020
Moderna and the US Biomedical Advanced Research and Development Authority (BARDA) have updated their contract for an additional funding commitment of up to $472m.